drugset / Trial / NCT00229112

Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)

NCT00229112 ↗

Phase 3 Completed 400 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare the efficacy, safety and tolerability of intravenous ertapenem versus another intravenous antibiotic in the treatment of moderate to severe diabetic foot infections.

Timeline

Start
2001-04
Primary completion
2004-04
Completion
2004-04

Outcome

Met primary endpoint

paper Clinical and microbiological outcomes for patients treated with ertapenem were equivalent to those for patients treated with piperacillin/tazobactam PMID 16291062 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ertapenem Small molecule 1 g Intravenous
Subject Piperacillin Small molecule — —
Subject Tazobactam Small molecule — —

Indications

No indication recorded.